Kingray Capital

Alebund Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for renal diseases and related chronic conditions. The company specializes in the research, development, regulatory approval, and commercialization of medicines aimed at treating various kidney diseases, including chronic kidney disease, complications associated with dialysis, nephropathy, diabetic kidney disease, and autosomal dominant polycystic kidney disease. With a diversified and balanced pipeline of drug candidates, Alebund Pharmaceuticals aims to provide comprehensive and high-quality solutions for patients suffering from renal diseases.

IMPACT Therapeutics, Inc. is a biotechnology company based in Shanghai, China, focused on discovering, developing, and commercializing innovative therapeutics for cancer and other life-threatening diseases. Founded in 2009, the company is dedicated to creating targeted anti-cancer treatments that leverage the concept of synthetic lethality. Its research and development efforts include a variety of novel drug projects, such as PARP inhibitors, Wee1 inhibitors, and agents targeting the Hedgehog pathway, among other DNA damage response (DDR) agents. Through its commitment to advancing targeted therapies, IMPACT Therapeutics aims to provide patients with new, effective treatment options for challenging medical conditions.

A new energy provides photovoltaic new energy system application solutions is committed to manufacturing and selling N-type high-efficiency photovoltaic cells, components, and system applications, as well as investing in and integrating power station construction and operation. They offer ecological photovoltaic, urban photovoltaic, and offshore PV solutions.

TopOlefin Technology specializes in the research, development, and production of advanced polymer materials, with a focus on high-end optical resins. The company is dedicated to creating products characterized by high transparency, high refractive index, and strong gas barrier properties. These innovative materials find applications across various industries, including optical lenses, medical packaging, and consumer packaging. By prioritizing green and intelligent design, TopOlefin Technology aims to deliver high-quality resin solutions that meet the diverse needs of its clients.

Zhitong Precision is a producer of industrial robots. They provide products that include machine tools, wind power, AGV cars, ships, construction machinery, and high-speed rail. They offer components and industrial automation production line solutions.

Trinomab Biotech is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel fully native human monoclonal antibody (mAb) drugs. The company's core technology is known as HitmAb, a proprietary technology platform with differentiated advantages and high efficiency for the discovery of fully native human mAbs against infectious diseases, autoimmune disorders, malignant tumors, and other human diseases.

Epigenic Therapeutics is a biotechnology company focused on developing gene editing therapies that leverage gene-silencing technology to address a range of diseases. The firm specializes in epigenome editing, aiming to regulate various conditions, including those related to ophthalmology, neurodegeneration, metabolism, and rare diseases. By creating innovative treatments, Epigenic Therapeutics seeks to offer effective solutions for patients suffering from chronic and severe health issues.

Linx Robot, founded in 2017 and based in Yuhang, China, specializes in the development of industrial robots tailored for warehousing, manufacturing, and logistics sectors. The company offers a range of products, including sorting systems, unpacking systems, package systems, vision cameras, and robot controllers. By focusing on industrial upgrading in areas such as advanced manufacturing, food, and agriculture, Linx Robot delivers innovative unmanned solutions that leverage computer vision technology and robotic intelligent planning. Their intelligent robot control systems and automation arms are designed to enhance operational efficiency and reliability in various industrial applications.

Blue Elephant Zhilian is a developer of a financial privacy computing platform. The company's platform are licensed under the Ministry of Industry and Information Technology and Ministry of Public Security of China.

Atom Bioscience is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory and metabolic diseases. The company concentrates on addressing conditions such as chronic gout, non-alcoholic steatohepatitis, diabetes, and colon cancers. By targeting the underlying mechanisms of metabolism and inflammation, Atom Bioscience aims to provide patients with more effective treatment options for these complex health issues.

Youibot Robotics Co., Ltd. is a Chinese company focused on the research, development, and manufacturing of autonomous mobile robots. The firm has independently developed a cutting-edge robot platform that utilizes advanced laser radar and visual real-time SLAM technology for navigation and mapping. Youibot's innovative systems are designed for both indoor and outdoor applications, offering competitive solutions for various industries. Their product line includes autonomous robots equipped with a standalone control system and a cluster collaboration platform, enabling efficient and automated operations for clients.

Star Theatre operates as a cultural and artistic hub in Southwest China, focusing on the development of the performing arts industry. It encompasses a theater and culture industrial park that produces drama and creative theater, while also advocating for literary and artistic life. The facility includes five distinct small theaters, contemporary art galleries, and themed restaurants, creating a vibrant environment for artistic expression and audience engagement. Star Theatre offers a range of services, including the design and development of artistic derivatives, copyright transactions, art exhibitions, and mass cultural activities. Additionally, it provides a space for book retail and the sale of audio-visual products, contributing to a comprehensive cultural experience for both artists and visitors. This innovative park serves as a platform for talent while also catering to the leisure interests of tourists through its diverse offerings.

Lanxin Mobile (Beijing) Technology Co., Ltd. is a mobile Internet company based in Beijing, China, that specializes in providing a work platform tailored for large organizations, including government agencies, state-owned enterprises, and the military. The platform is designed to enhance hierarchical decentralization and visibility management, facilitating work communication, multi-terminal viewing, and document security. It includes features such as multi-level directory permission control, video conferencing, and support for large conference calls, enabling users to locate individuals based on their attributes and organizational levels. Additionally, Lanxin offers cloud-based, AI-driven collaborative IT solutions that promote secure and efficient working environments, fostering digital transformation and organizational innovation.

Qi An Xin Group is a prominent cybersecurity company based in Beijing, China, specializing in the protection of critical internet assets across various sectors, including government, finance, energy, and telecommunications. Founded in 2015, the company has experienced rapid growth, achieving over 90% consecutive compound annual growth rate since its inception. Qi An Xin offers a range of security solutions, including big data security, endpoint security, content security, and advanced detection and monitoring systems for cyber threats such as DDoS attacks and phishing. With a workforce of over 6,000 professionals, the company has successfully implemented its technologies in approximately 90% of government departments, state-owned enterprises, and major banks in China. Since 2019, Qi An Xin has also begun expanding its international presence, establishing operations in countries such as Indonesia, Singapore, Canada, Hong Kong, and Macao.